Clinical trial
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have…
NCT00002559 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002559 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin |
| Official title | PHASE I/II TRIAL OF TAXOL, IFOSFAMIDE, AND CISPLATIN FOR CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH FAVORABLE PROGNOSTIC FEATURES |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, ifosfamide, paclitaxel |
| Enrollment | 43 |
| Start date | Jan 1, 1994 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | Sep 18, 2003 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: